FI940355A0 - Yhdisteet, joilla on angiotensiini II:ta vastustava vaikutus - Google Patents
Yhdisteet, joilla on angiotensiini II:ta vastustava vaikutusInfo
- Publication number
- FI940355A0 FI940355A0 FI940355A FI940355A FI940355A0 FI 940355 A0 FI940355 A0 FI 940355A0 FI 940355 A FI940355 A FI 940355A FI 940355 A FI940355 A FI 940355A FI 940355 A0 FI940355 A0 FI 940355A0
- Authority
- FI
- Finland
- Prior art keywords
- angiotensin
- activity
- compounds
- Prior art date
Links
- 229950006323 angiotensin ii Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI912182A IT1250749B (it) | 1991-08-02 | 1991-08-02 | Composti eterociclici ad attivita' a ii antagonista |
| PCT/EP1992/001753 WO1993003018A1 (en) | 1991-08-02 | 1992-08-03 | Compounds having angiotensine ii antagonistic activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI940355A FI940355A (fi) | 1994-01-25 |
| FI940355A0 true FI940355A0 (fi) | 1994-01-25 |
Family
ID=11360517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI940355A FI940355A0 (fi) | 1991-08-02 | 1994-01-25 | Yhdisteet, joilla on angiotensiini II:ta vastustava vaikutus |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5565464A (fi) |
| EP (1) | EP0641329A1 (fi) |
| JP (1) | JPH06509349A (fi) |
| AU (1) | AU668357B2 (fi) |
| BG (1) | BG61692B1 (fi) |
| CA (1) | CA2114621A1 (fi) |
| CZ (1) | CZ16994A3 (fi) |
| FI (1) | FI940355A0 (fi) |
| HU (1) | HUT67666A (fi) |
| IT (1) | IT1250749B (fi) |
| PL (1) | PL174986B1 (fi) |
| RO (1) | RO113987B1 (fi) |
| SK (1) | SK10694A3 (fi) |
| WO (1) | WO1993003018A1 (fi) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100300566B1 (ko) * | 1994-09-17 | 2001-11-22 | 조생현 | 피리미디논유도체와그의제조방법및용도 |
| IT1283620B1 (it) * | 1996-04-19 | 1998-04-22 | Luso Farmaco Inst | "pirimidin-4-oni n-3 sostituiti ad attivita' aii antagonista" |
| CA2176058C (en) * | 1996-05-08 | 1999-03-02 | William Nicholas Goodway | Three-dimensional seismic acquisition |
| DK1027328T3 (da) * | 1997-10-31 | 2006-11-13 | Aventis Pharma Ltd | Substituerede anilider |
| SE9903028D0 (sv) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
| JP2007504136A (ja) * | 2003-08-28 | 2007-03-01 | ニトロメッド インコーポレーティッド | ニトロソ化およびニトロシル化利尿化合物、組成物、ならびに使用方法 |
| JP2008531697A (ja) * | 2005-02-28 | 2008-08-14 | ニトロメッド インコーポレーティッド | 酸化窒素増強基を含む心血管化合物、組成物および使用法 |
| US20090215838A1 (en) * | 2005-03-09 | 2009-08-27 | Nitromed, Inc. | Organic nitric oxide enhancing salts of angiotensin ii antagonists, compositions and methods of use |
| US8193206B2 (en) | 2005-06-14 | 2012-06-05 | Taigen Biotechnology Co., Ltd. | Pyrimidine compounds |
| WO2006138304A2 (en) * | 2005-06-14 | 2006-12-28 | Taigen Biotechnology | Pyrimidine compounds |
| JP2010510962A (ja) * | 2006-11-24 | 2010-04-08 | 武田薬品工業株式会社 | 複素単環化合物およびその用途 |
| US7803940B2 (en) * | 2006-11-24 | 2010-09-28 | Takeda Pharmaceutical Company Limited | Heteromonocyclic compound or a salt thereof having strong antihypertensive action, insulin sensitizing activity and the like production thereof and use thereof for prophylaxis or treatment of cardiovascular diseases, metabolic diseases and/or central nervous system diseases |
| EA020466B1 (ru) | 2007-06-04 | 2014-11-28 | Синерджи Фармасьютикалз Инк. | Агонисты гуанилатциклазы, пригодные для лечения желудочно-кишечных нарушений, воспаления, рака и других заболеваний |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| CA2726917C (en) | 2008-06-04 | 2018-06-26 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| CA2730603C (en) | 2008-07-16 | 2019-09-24 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| TW201444848A (zh) * | 2009-01-30 | 2014-12-01 | Takeda Pharmaceutical | 稠環化合物及其用途 |
| WO2010119700A1 (ja) | 2009-04-17 | 2010-10-21 | 興和株式会社 | 新規な３-ヘテロアリールピリミジン-４-(３ｈ)-オン構造を有する化合物及びこれを含有する医薬 |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| CN113388007A (zh) | 2013-06-05 | 2021-09-14 | 博士医疗爱尔兰有限公司 | 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法 |
| KR102131022B1 (ko) * | 2018-07-12 | 2020-07-07 | 보령제약 주식회사 | 피리미디논 유도체 화합물 및 이의 용도 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0424317A3 (en) * | 1989-10-19 | 1991-09-25 | Ciba-Geigy Ag | Pyrimidines |
| EP0435827A3 (en) * | 1989-12-28 | 1991-11-13 | Ciba-Geigy Ag | Diaza compounds |
| US5166206A (en) * | 1990-03-30 | 1992-11-24 | Merck & Co., Inc. | Substituted pyrimidines, pyrimidinones and pyridopyrimidines |
| CA2079344A1 (en) * | 1990-03-30 | 1991-10-01 | Eric E. Allen | Substituted pyrimidines, pyrimidinones and pyridopyrimidines |
| IE912114A1 (en) * | 1990-07-02 | 1992-01-15 | Union Pharma Scient Appl | Novel pyrimidine derivatives which are angiotensin ii¹receptor antagonists, their methods of preparation and¹pharmaceutical compositions in which they are present |
-
1991
- 1991-08-02 IT ITMI912182A patent/IT1250749B/it active IP Right Grant
-
1992
- 1992-08-03 HU HU9400267A patent/HUT67666A/hu unknown
- 1992-08-03 CZ CZ94169A patent/CZ16994A3/cs unknown
- 1992-08-03 JP JP5503271A patent/JPH06509349A/ja active Pending
- 1992-08-03 AU AU23873/92A patent/AU668357B2/en not_active Ceased
- 1992-08-03 WO PCT/EP1992/001753 patent/WO1993003018A1/en not_active Application Discontinuation
- 1992-08-03 US US08/193,025 patent/US5565464A/en not_active Expired - Fee Related
- 1992-08-03 CA CA002114621A patent/CA2114621A1/en not_active Abandoned
- 1992-08-03 PL PL92302346A patent/PL174986B1/pl unknown
- 1992-08-03 EP EP92916506A patent/EP0641329A1/en not_active Withdrawn
- 1992-08-03 SK SK106-94A patent/SK10694A3/sk unknown
- 1992-08-03 RO RO94-00144A patent/RO113987B1/ro unknown
-
1994
- 1994-01-25 FI FI940355A patent/FI940355A0/fi unknown
- 1994-01-31 BG BG98430A patent/BG61692B1/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RO113987B1 (ro) | 1998-12-30 |
| HU9400267D0 (en) | 1994-05-30 |
| CZ16994A3 (en) | 1994-06-15 |
| ITMI912182A1 (it) | 1993-02-03 |
| FI940355A (fi) | 1994-01-25 |
| AU2387392A (en) | 1993-03-02 |
| JPH06509349A (ja) | 1994-10-20 |
| HUT67666A (en) | 1995-04-28 |
| WO1993003018A1 (en) | 1993-02-18 |
| CA2114621A1 (en) | 1993-02-18 |
| BG61692B1 (bg) | 1998-03-31 |
| AU668357B2 (en) | 1996-05-02 |
| PL174986B1 (pl) | 1998-10-30 |
| BG98430A (bg) | 1994-09-30 |
| IT1250749B (it) | 1995-04-21 |
| ITMI912182A0 (it) | 1991-08-02 |
| US5565464A (en) | 1996-10-15 |
| SK10694A3 (en) | 1994-12-07 |
| EP0641329A1 (en) | 1995-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI940355A (fi) | Yhdisteet, joilla on angiotensiini II:ta vastustava vaikutus | |
| MX9201819A (es) | Compuestos benzoheterociclicos. | |
| FI921708A (fi) | Stolstoppning, speciellt flygplansfaotoelj | |
| FI922494A (fi) | Pulverformig, enzymer innehaollande diskmedelskomposition foer automatiska diskmaskiner | |
| FI934919A0 (fi) | Avgivningssystem med kontrollerad, foerlaengd frigivning foer roekavvaenjning | |
| MX9205145A (es) | Nuevos derivados heterociclicos. | |
| MX9202978A (es) | Compuestos de amino-4-aril-tiazoles. | |
| MX9200560A (es) | Compuesto de piridina. | |
| FR2678999B1 (fr) | Distributeur. | |
| FI922654A (fi) | Saekringsanordning foer avtryckarmekanismer, isynnerhet foer eldvapen | |
| MX9202690A (es) | Nuevos compuestos de cefem. | |
| FI925411A0 (fi) | Fartyg, speciellt handelsfartyg | |
| FR2684318B1 (fr) | Sorbonne perfectionnee. | |
| FI921759A (fi) | Lineaer viskoelastisk vattenhaltig flytande detergentkomposition, speciellt foer automatiska diskmaskiner | |
| FI923542A (fi) | Faestanordning foer klingor, isynnerhet i bestrykningsmaskiner | |
| FI924395A (fi) | Icke-a, icke-b-peptider | |
| FI922490A (fi) | Vattenfri, flytande, enzymer innehaollande diskmedelskomposition foer automatiska diskmaskiner | |
| FI921760A (fi) | Viskoelastisk vattenhaltig flytande detergentkomposition, speciellt foer automatiska diskmaskiner med foerbaettrad doserbarhet | |
| NO912250D0 (no) | Egnessystem for line. | |
| ES1019664Y (es) | Sandwichera perfeccionada. | |
| FI922498A (fi) | Lineaert viskoelastisk, vattenhaltig, flytande tvaettmedelskomposition foer automatiska diskmaskiner | |
| FI922502A (fi) | Fosfatfria gellika tvaettmedelskompositioner, avsedda foer automatiska diskmaskiner | |
| ES1016780Y (es) | Cascador-rompedor perfeccionado. | |
| MX9202143A (es) | Compuestos. | |
| ES1018315Y (es) | Zancos perfeccionados. |